Skip to main content
Advertisement
Advertisement
SGRY
SGRY logo
Surgery Partners, Inc. Common Stock
23.24
USD
Sponsored
-0.12
-0.51%
Oct 28, 15:59 UTC -4
Closed
exchange

Pre-Market

23.24

0.00
0.00%

Surgery Partners, Inc. Common Stock (SGRY) Earnings

SGRY Earnings Reports

Positive Surprise Ratio

SGRY beat 20 of 43 last estimates.

47%

Next Report

Date of Next Report
Nov 10, 2026
Estimate for Q3 26 (Revenue/ EPS)
$863.27M
/
$0.13
Implied change from Q2 26 (Revenue/ EPS)
+1.69%
/
+30.00%
Implied change from Q3 25 (Revenue/ EPS)
+5.08%
/
--

Surgery Partners, Inc. Common Stock earnings per share and revenue

On Aug 10, 2026, SGRY reported earnings of 0.10 USD per share (EPS) for Q2 26, beating the estimate of 0.05 USD, resulting in a 68.07% surprise. Revenue reached 848.90 million, compared to an expected 846.97 million, with a 0.23% difference. The market reacted with a +2.70% price change (close before vs. close after earnings).
Looking ahead to Q3 26, 10 analysts forecast an EPS of 0.13 USD, with revenue projected to reach 863.27 million USD, implying an increase of 30.00% EPS, and increase of 1.69% in Revenue from the last quarter.

Industry Peers’ Earnings

Industry Peers' Earnings displays EPS earnings data from companies in the same industry. Click on a card to view more details.

logo
Bausch + Lomb Corporation
Report Date
Oct 28, 2026 For Q3 26
Estimate
$0.22
Actual
$0.34
Surprise
+53.43%
logo
Pediatrix Medical Group, Inc.
Report Date
Oct 29, 2026 For Q3 26
Estimate
$0.66
Actual
$0.72
Surprise
+7.61%
logo
Establishment Labs Holdings Inc.
Report Date
Oct 29, 2026 For Q3 26
Estimate
-$0.26
Actual
-$0.35
Surprise
-33.69%
logo
Danaher Corporation
Report Date
Oct 21, 2026 For Q3 26
Estimate
$1.93
Actual
$2.11
Surprise
+8.99%
logo
HCA Healthcare, Inc.
Report Date
Oct 27, 2026 For Q3 26
Estimate
$6.72
Actual
$7.22
Surprise
+7.29%
logo
Elevance Health, Inc.
Report Date
Oct 21, 2026 For Q3 26
Estimate
$4.72
Actual
$6.99
Surprise
+47.81%
logo
Labcorp Holdings Inc.
Report Date
Oct 28, 2026 For Q3 26
Estimate
$4.79
Actual
$4.78
Surprise
-0.31%
logo
Medpace Holdings, Inc. Common Stock
Report Date
Oct 21, 2026 For Q3 26
Estimate
$4.52
Actual
$4.84
Surprise
+6.98%
logo
Icon Plc
Report Date
Oct 27, 2026 For Q3 26
Estimate
$2.65
Actual
$2.66
Surprise
+0.27%
logo
Avantor, Inc.
Report Date
Oct 28, 2026 For Q3 26
Estimate
$0.21
Actual
$0.22
Surprise
+3.92%
FAQ
For Q2 2026, Surgery Partners, Inc. Common Stock reported EPS of $0.10, beating estimates by 68.07%, and revenue of $848.90M, 0.23% above expectations.
The stock price moved up 2.7%, changed from $15.53 before the earnings release to $15.95 the day after.
The next earning report is scheduled for Nov 10, 2026.
Based on 10 analysts, Surgery Partners, Inc. Common Stock is expected to report EPS of $0.13 and revenue of $863.27M for Q3 2026.
Check FXEmpire's Earnings Calendar for today's list of reporting companies.
Advertisement